CIMT Meetings

CIP co-organizes dedicated immunoguiding sessions at the CIMT Annual Meeting and conferences


CIMT 2018

Day 3 - May 17,  2018 - Plenary session 5: Immunoguiding

Günther J. Hämmerling German Cancer Research Center DKFZ (Heidelberg, Germany)
Reprogramming the tumor microenvironment for efficient cancer immunotherapy

Dimitirios Mastellos National Center for Scientfic Research ‘Demokritos’ (Athens, Greece)
Complement in cancer: untangling an intricate relationship

Nicholas McGranahan, Cancer Research UK Lung Cancer Centre of Excellence (London, United Kingdom)
Lung cancer evolution and immune escape

Day 3 - May 17, Short Talk session V: Immunomonitoring

Rodrigo Nalio Ramos Institute Curie, Paris, France
High dimensional analysis of the myeloid cell landscape in human breast cancer metastatic lymph nodes

Saskia J.A.M. Santegoets Leiden University Medical Center, Leiden, Netherlands
The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival

Tripti Tamhane Technical University of Denmark, Lyngby, Denmark
Empty MHC class I molecules: An alternate, convenient, and improved detection tool for antigen specific T cells

Alexander Ulges Immatics Biotechnologies GmbH, Tübingen, Germany
Immunomonitoring for personalized cancer immunotherapies via ex vivo combinatorial workflow and concurrent high-resolution class I & II ICS

Henning Zelba University Medical Center Tübingen, Tübingen, Germany
Disappearance of NY-ESO-1 and Melan-A-specific T-cells from peripheral blood is associated with clinical response in melanoma patients undergoing anti-PD-1 therapy

For more information, please see the CIMT 2018 meeting program 

Immunomonitoring Poster Award

Jonas Bochem, University Medical Center Tübingen
Abstract #034

“Peripheral blood NKT-cell frequencies and their PD-1 expression levels identify stage IV melanoma patients with poor overall survival under PD-1/CTLA-4 blockade”

Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, Sept 2017, Mainz

CIP presented a series of posters on all activities of the working group

CIMT 2017 Anniversary Symposium, May 2017

Immunoguiding Seminar Speakers: Javier Romero Ros (Academic Medical Center, Amsterdam), Sven Brandau (University Hospital Essen), Tanja de Gruijl (VU University Medical Center Amsterdam), Angela M. Krackhardt (Technical University Munich)

CIP Meeting events Archive:

CIMT 2016

Day 3 - May 12,  2016 - Plenary session 5: Novel Technologies for Immune Assessment

Timothy Tree King's College (London, United Kingdom)
Measuring regulatory T cell phenotype and function in human health and disease

Sine Reker Hadrup Technical University of Denmark (Copenhagen, Denmark)
Next-generation detection of cancer-responsive T cells

Giuliano Elia, Philochem (Otelfingen, Switzerland)
A phase III trial of the intralesional application of L19IL2/L19TNF in stage IIIB/C melanoma patients

Day 3 - May 12, Short Talk session VI: Immunomonitoring

Amalie Kai Bentzen Technical University of Denmark (Copenhagen, Denmark)
Next-generation detection of cancer-responsive T cells using DNA barcode-labeled
peptide-Major Histocompatibility Complex I multimers

Coco de Koning UMC (Utrecht, The Netherlands)
CD4+ T-cell immunomonitoring after hematopoietic cell transplantation:
identifying patients at risk for virus-predicted adverse outcomes

Gabriele Niedermann University Clinics (Freiburg, Germany)
Noninvasive ImmunoPET imaging of the PD-1/PD-L1 checkpoint in naïve and irradiated tumor-bearing mice

Paulo Rodrigues-Santos Faculdade de Medicina da Universidade de Coimbra (Coimbra, Portugal)
Immune monitoring of natural killer cells in chronic myeloid leukemia:
split anergy status depend on tyrosine kinase inhibitor therapy

Julien Schmidt Ludwig Center (Lausanne, Switzerland)
Isolation and analysis of tumor-specific CD8 and CD4 T cells with high affinity, reversible pMHC multimers

CIMT 2015

Day 1 - May 11, 2015 - Symposium on Computational Tools for Biomarker Discovery

Ryan Brinkman British Columbia Cancer Agency (Vancouver BC, Canada)
Computational tools for flow cytometry and how well they work

Sylvia Janetzki ZellNet Consulting (Fort Lee,USA)
The age of computing: challenges in data analysis for functional immune assays

Tomas Kalina Charles University (Prague, Czech Republic)
How standardization of flow cytometry facilitates computational analyses - EuroFlow experience

Pratip Chattopadhyay National Institutes of Health (Bethesda, USA)
The next dimension in single cell cytometry: integrating computational tools for more powerful experiments

Pia Kvistborg (National Cancer Institute Amsterdam The Netherlands) and Marij Welters (LUMC, Leiden, The Netherlands)
Update on CIP activities and closing words

CIP Committee and Speakers at 2015 CIMT Annual Meeting in Mainz

CIP Committee and Speakers at 2015 CIMT Annual Meeting in Mainz

Day 3 - May 13, 2015 Short talk session VI / Immunomonitoring

Katharina Epp Johannes Gutenberg-Universität (Mainz, Germany)
Functionally impaired GPI-anchor negative regulatory T cells strongly correlate with acute Graft versus Host Disease after Alemtuzumab-based conditioning regimen

Keisuke Fujii University Graduate School of Medicine (Mie, Japan)
Development of a novel rapid and sensitive method for detection of cellular immune responses and selection of immunogenic peptides encoded by mutated genes

Jan Dörrie University Hospital (Erlangen, Germany)
Electroporation of CD8+ effector T cells with antigen is suitable to test their reactivity to tumor antigens

Jithendra Kini Bailur University Hospital (Tübingen, Germany)
Prognostic impact of circulating plasmacytoid dendritic cells and immunosuppressive subsets in breast cancer

Sofie Ramskov Andersen Technical University/National Veterinary Institute (Copenhagen, Denmark)
Identification of novel T cell epitopes in breast cancer

CIMT 2014

Day 1 - May 6, 2014 - CIP Breakout Session

Steffen Walter immatics biotechnologies GmbH (Tübingen, Germany) MDSC Phenotyping Proficiency Panel

Ruth Challis University of Southampton (Southampton, United Kingdom)
Preliminary results from the NK harmonization panel

Henrik Pedersen Immudex (Copenhagen, Denmark)
MHC Multimer Proficiency Panel 2014: The data obtained prove high reproducibility of the MHC Multimer assay

Nicole Bidmon University Medical Center Mainz (Mainz, Germany)
TCR-engineered reference samples (TERS) to control T-cell assay performance –towards an immune-control kit

Saskia Santegoets Leiden University Medical Center (Leiden, The Netherlands)
Results of the CIP workshop on the detection and functional testing of (antigen-specific) regulatory T cells

Pia Kvistborg Netherlands Cancer Institute (Amsterdam, The Netherlands)
Automated analysis of flow cytometry data – bridging two worlds

Cliburn Chan Duke University (Durham, USA) 
Managing multi-center flow cytometry data for cancer immune monitoring

Day 2 - May 7, 2014 - Plenary Session 4 / Immunoguiding

Eric Vivier Centre d´Immunologie (Marseille, France)
Natural killer cells and innate lymphoid cells

Pedro Romero Ludwig Institute for Cancer Research (Lausanne, Switzerland)
Monitoring tumor antigen-specific T-cell responses

Day 3 - May 8, 2014 - Short Talk Session V / Immunomonitoring

Petra Baumgärtner Ludwig Institute for Cancer Research (Lausanne, Switzerland)
Survival of melanoma patients correlating with DTH skin reactions and CD8 T cell/ Treg ratios in PBMC after vaccinations with CpG & peptides

Julia Fischer Institute for Virology and Immunobiology (Würzburg, Germany)
Resetting circulating CD8 T-cells to a tissue-like status permits sensitive detection of their responses to virus- and tumor-associated antigens

Michael Hebeisen  Lausanne University Hospital (Lausanne, Switzerland)
Reversible NTAmer technology enables rapid and direct detection of monomeric TCRpMHC kinetics at the cell surface and predicts tumor-specific T cell responsiveness

Jithendra Kini Bailur University Hospital (Tübingen, Germany)
Presence of circulating Her-2-reactive CD8 T-cells is associated with lower frequency of MDSCs and better survival in elderly breast cancer patients

Oliver Lantz  Institut Curie and INSERM (Paris, France)
High numbers of differentiated effector CD4 T cells are found in cancer patients and correlate with clinical response after neo-adjuvant therapy of breast cancer